X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4323) 4323
Publication (277) 277
Book Review (70) 70
Book Chapter (32) 32
Dissertation (11) 11
Magazine Article (8) 8
Conference Proceeding (7) 7
Paper (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
donepezil (3728) 3728
humans (2243) 2243
alzheimer's disease (1806) 1806
male (1505) 1505
index medicus (1461) 1461
dementia (1315) 1315
aged (1221) 1221
alzheimer disease - drug therapy (1216) 1216
female (1205) 1205
alzheimers-disease (1044) 1044
cholinesterase inhibitors - therapeutic use (986) 986
clinical neurology (892) 892
pharmacology & pharmacy (847) 847
double-blind (845) 845
neurosciences (845) 845
rivastigmine (798) 798
psychiatry (793) 793
indans - therapeutic use (747) 747
piperidines - therapeutic use (747) 747
aged, 80 and over (684) 684
galantamine (630) 630
efficacy (598) 598
middle aged (596) 596
animals (589) 589
treatment outcome (578) 578
geriatrics & gerontology (572) 572
memantine (521) 521
cholinesterase inhibitors (495) 495
cholinesterase inhibitors - pharmacology (464) 464
placebo-controlled trial (463) 463
acetylcholinesterase (406) 406
nootropic agents - therapeutic use (406) 406
piperidines - pharmacology (395) 395
indans - pharmacology (393) 393
drug therapy (388) 388
memory (378) 378
cholinesterase-inhibitors (372) 372
alzheimers disease (370) 370
neuropsychological tests (357) 357
rats (344) 344
alzheimer disease - psychology (314) 314
cognition (312) 312
safety (306) 306
cholinesterase inhibitors - adverse effects (302) 302
moderate (302) 302
analysis (296) 296
brain (288) 288
double-blind method (275) 275
acetylcholinesterase inhibitors (268) 268
cognitive ability (256) 256
diagnosis (256) 256
piperidines - adverse effects (251) 251
indans - adverse effects (250) 250
alzheimer’s disease (249) 249
gerontology (249) 249
acetylcholine (245) 245
cognition disorders - drug therapy (245) 245
dose-response relationship, drug (244) 244
tacrine (240) 240
mild cognitive impairment (238) 238
cholinesterase inhibitors - administration & dosage (237) 237
adult (234) 234
medicine, general & internal (227) 227
severity of illness index (226) 226
neurology (225) 225
neurodegenerative diseases (223) 223
piperidines - administration & dosage (222) 222
indans - administration & dosage (218) 218
activities of daily living (217) 217
clinical trials (216) 216
cognitive impairment (215) 215
care and treatment (213) 213
dementia - drug therapy (213) 213
cognition - drug effects (212) 212
memantine - therapeutic use (209) 209
vascular dementia (207) 207
research (206) 206
mice (202) 202
alzheimer disease - diagnosis (201) 201
donepezil hydrochloride (198) 198
alzheimer disease (197) 197
drugs (190) 190
alzheimer disease - physiopathology (186) 186
acetylcholinesterase inhibitor (183) 183
galantamine - therapeutic use (181) 181
therapy (180) 180
chemistry, medicinal (178) 178
time factors (176) 176
acetylcholinesterase - metabolism (168) 168
cholinesterase inhibitor (167) 167
disease progression (156) 156
psychiatric status rating scales (148) 148
brain - drug effects (147) 147
randomized controlled trials as topic (147) 147
trial (147) 147
prevalence (146) 146
disease (145) 145
impairment (141) 141
clinical trials as topic (139) 139
phenylcarbamates - therapeutic use (139) 139
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4100) 4100
Japanese (66) 66
German (58) 58
Spanish (57) 57
French (39) 39
Turkish (10) 10
Portuguese (9) 9
Russian (8) 8
Chinese (7) 7
Italian (7) 7
Korean (6) 6
Persian (5) 5
Czech (4) 4
Hungarian (2) 2
Bosnian (1) 1
Croatian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Dementia and Geriatric Cognitive Disorders, ISSN 1420-8008, 05/2006, Volume 21, Issue 5-6, pp. 353 - 363
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 07/2018, Volume 281, pp. 139 - 177
Journal Article
Donepezil hydrochloride: a double-blind study in autistic children, 2003
Recent studies in autistic brain samples have shown diminished acetylcholine and nicotinic receptor activity. We hypothesized that acetylcholinergic... 
Neurology | Pediatrics | autism, autistic spectrum disorder, donepezil hydrochloride pn03015
Journal
Journal Article
Journal of Cardiovascular Pharmacology and Therapeutics, ISSN 1074-2484, 2019, p. 1074248419838509
Donepezil may have cardioprotective properties, but the mechanism is unclear. Using positron-emission tomography (PET), we explored C-donepezil uptake in the... 
donepezil | C-donepezil PET | ageing | cardiac protection | heart
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 03/2014, Volume 75, pp. 82 - 95
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2017, Volume 799, pp. 1 - 6
Idalopirdine (Lu AE58054) is a high affinity and selective antagonist for the human serotonin 5-HT receptor (K 0.83 nM) in phase III development for... 
Idalopirdine | receptor | Donepezil | Serotonin 5-HT | Alzheimer's disease
Journal Article
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, ISSN 1735-7799, 06/2019, Volume 13, Issue 4, pp. 1 - 10
Background and Objectives: Alphapinene as one of the most important Components of essential oils, which has antioxidant and anti-cholinesterase activities.... 
Rat | Memory | Donepezil | Alphapinene
Journal Article
Journal Article
Progress in Neuro-Psychopharmacology and Biological Psychiatry, ISSN 0278-5846, 02/2002, Volume 26, Issue 2, pp. 369 - 373
Objectives: The aim of this study was to evaluate the long-term efficacy, safety and tolerability of donepezil in the treatment of Alzheimer's disease (AD).... 
donepezil
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2012, Volume 366, Issue 10, pp. 893 - 903
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 07/2019, Volume 140, Issue 3, pp. 291 - 294
Oxaliplatin induces severe peripheral neuropathy. The effect of donepezil, a drug used for treatment of Alzheimer's disease, on oxaliplatin-induced peripheral... 
Peripheral neuropathy | Donepezil | Oxaliplatin
Journal Article
Neuroscience, ISSN 0306-4522, 10/2000, Volume 101, Issue 1, pp. 89 - 100
In the symptomatic treatment of mild to moderately severe dementia associated with Alzheimer's disease, donepezil (E2020) has been introduced for the... 
donepezil
Journal Article
Bioorganic and Medicinal Chemistry, ISSN 0968-0896, 02/2013, Volume 21, Issue 3, pp. 676 - 683
Four series of novel heterodimers comprised of donepezil and huperzine A (HupA) fragments were designed, synthesized, and evaluated in search of potent... 
donepezil | Acetylcholinesterase | Huperzine A
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 02/2016, Volume 38, Issue 1, pp. 108 - 113
Background:In humans, donepezil (D) is metabolized to 5-O-desmethyl-donepezil (5DD), 6-O-desmethyl-donepezil (6DD), and donepezil-N-oxide (DNox). Although 6DD... 
donepezil-N-oxide | 5-O-desmethyl-donepezil | HPLC assay | Donepezil | 6-O-desmethyl-donepezil | donepezil |